Inovio Pharmaceuticals secures a patent for innovative nucleic acid molecules targeting Survivin-expressing tumors, paving the way for advanced cancer therapies and vaccines.
* Beyond Air’s LungFit PH is approved for commercial use only in the United States of America to treat term and near-term neonates with hypoxic respiratory failure. Beyond Air’s other LungFit systems ...